abstract |
The invention relates to pyridinone derivatives as inhibitors of tissue transglutaminase, to processes for preparing the pyridinone derivatives, to pharmaceutical compositions containing these pyridinone derivatives and to their use for the prophylaxis and treatment of tissue transglutaminase-associated diseases. |